TuHURA BIOSCIENCES, INC./NV Dividends, Preferred Stock, Stock
TuHURA BIOSCIENCES, INC./NV (HURA) reported Dividends, Preferred Stock, Stock of $2.09 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Shareholders' Equity › Dividends, Preferred Stock
us-gaap:DividendsPreferredStockStock · last filed 2025-03-31
- TuHURA BIOSCIENCES, INC./NV dividends, preferred stock, stock for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV dividends, preferred stock, stock for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV dividends, preferred stock, stock for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV dividends, preferred stock, stock for the quarter ending 2020-09-30 was $3.18M, a 155374.10% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV dividends, preferred stock, stock for fiscal 2024 was $2.09K.
- TuHURA BIOSCIENCES, INC./NV dividends, preferred stock, stock for fiscal 2021 was $3.18M, a 36819.68% increase from fiscal 2020.
- TuHURA BIOSCIENCES, INC./NV dividends, preferred stock, stock for fiscal 2020 was $8.62K, a 89.29% decline from fiscal 2019.
- TuHURA BIOSCIENCES, INC./NV dividends, preferred stock, stock for fiscal 2019 was $80.43K, a 54.36% decline from fiscal 2018.
| Period end | Dividends, Preferred Stock, Stock 3 month | Dividends, Preferred Stock, Stock 6 month | Dividends, Preferred Stock, Stock 9 month | Dividends, Preferred Stock, Stock 12 month |
|---|---|---|---|---|
| 2024-12-31 | $2.09K 10-K · filed 2025-03-31 | |||
| 2021-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $0.00 derived: sum of 2 quarters · filed 2022-09-27 | $0.00 derived: sum of 3 quarters · filed 2022-09-27 | $3.18M 10-K · filed 2022-09-27 |
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-13 | $0.00 derived: sum of 2 quarters · filed 2022-05-13 | $3.18M 10-Q · filed 2022-05-13 | $3.18M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-11 | $3.18M 10-Q · filed 2022-02-11 | $3.18M derived: sum of 3 quarters · filed 2022-02-11 | $3.19M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-09-30 | $3.18M 10-Q · filed 2021-11-15 | $3.18M derived: sum of 2 quarters · filed 2021-11-15 | $3.19M derived: sum of 3 quarters · filed 2021-11-15 | $3.19M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $2.54K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-18 | $4.02K derived: sum of 2 quarters · filed 2020-09-18 | $6.57K derived: sum of 3 quarters · filed 2020-09-18 | $8.62K 10-K · filed 2020-09-18 |
| 2020-03-31 | $1.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-13 | $4.03K derived: sum of 2 quarters · filed 2020-05-13 | $6.07K 10-Q · filed 2020-05-13 | $11.03K derived: sum of 4 quarters · filed 2020-09-18 |
| 2019-12-31 | $2.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-13 | $4.60K 10-Q · filed 2020-02-13 | $9.55K derived: sum of 3 quarters · filed 2020-09-18 | $32.75K derived: sum of 4 quarters · filed 2020-09-18 |
| 2019-09-30 | $2.05K 10-Q · filed 2019-11-13 | $7.00K derived: sum of 2 quarters · filed 2020-09-18 | $30.20K derived: sum of 3 quarters · filed 2020-09-18 | $46.39K derived: sum of 4 quarters · filed 2020-09-18 |
| 2019-06-30 | $4.95K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-18 | $28.16K derived: sum of 2 quarters · filed 2020-09-18 | $44.35K derived: sum of 3 quarters · filed 2020-09-18 | $80.43K 10-K · filed 2020-09-18 |
| 2019-03-31 | $23.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-13 | $39.39K derived: sum of 2 quarters · filed 2020-05-13 | $75.48K 10-Q · filed 2020-05-13 | $109.36K derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $16.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-13 | $52.27K 10-Q · filed 2020-02-13 | $86.15K derived: sum of 3 quarters · filed 2020-02-13 | $132.78K derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-09-30 | $36.09K 10-Q · filed 2019-11-13 | $69.96K derived: sum of 2 quarters · filed 2019-11-13 | $116.59K derived: sum of 3 quarters · filed 2019-11-13 | $170.66K derived: sum of 4 quarters · filed 2019-11-13 |
| 2018-06-30 | $33.88K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-09 | $80.50K derived: sum of 2 quarters · filed 2019-09-09 | $134.57K derived: sum of 3 quarters · filed 2019-09-09 | $176.24K 10-K · filed 2019-09-09 |
| 2018-03-31 | $46.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-14 | $100.69K derived: sum of 2 quarters · filed 2019-05-14 | $142.36K 10-Q · filed 2019-05-14 | $255.95K derived: sum of 4 quarters · filed 2019-06-03 |
| 2017-12-31 | $54.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-11 | $95.73K 10-Q · filed 2019-02-11 | $209.32K derived: sum of 3 quarters · filed 2019-06-03 | $419.13K derived: sum of 4 quarters · filed 2019-06-03 |
| 2017-09-30 | $41.67K 10-Q · filed 2018-11-13 | $155.25K derived: sum of 2 quarters · filed 2019-06-03 | $365.07K derived: sum of 3 quarters · filed 2019-06-03 | $524.82K derived: sum of 4 quarters · filed 2019-06-03 |
| 2017-06-30 | $113.59K derived: 8-K 12 month − 10-Q 9 month · filed 2019-06-03 | $323.40K derived: sum of 2 quarters · filed 2019-06-03 | $483.16K derived: sum of 3 quarters · filed 2019-06-03 | $790.45K 8-K · filed 2019-06-03 |
| 2017-03-31 | $209.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-15 | $369.57K derived: sum of 2 quarters · filed 2018-05-15 | $676.87K 10-Q · filed 2018-05-15 | |
| 2016-12-31 | $159.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14 | $467.05K 10-Q · filed 2018-02-14 | ||
| 2016-09-30 | $307.30K 10-Q · filed 2017-11-09 | |||
| 2016-06-30 | $238.33K 10-K · filed 2017-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |